May 13, 2022
The “Twincretin” era for treating patients with type 2 diabetes has begun, with the US Food and Drug Administration’s approval of tirzepatide for this indication on […]
May 13, 2022
The “Twincretin” era for treating patients with type 2 diabetes has begun, with the US Food and Drug Administration’s (FDA’s) approval of tirzepatide for this indication […]
May 13, 2022
Calling the death of 75-year-old patient Charlene Murphey a “terrible, terrible mistake,” a Tennessee judge sentenced former nurse RaDonda Vaught, RN, to 3 years of supervised […]
May 13, 2022
The US Food and Drug Administration (FDA) has approved the Onyx Frontier drug-eluting stent (DES) to treat patients with coronary artery disease, the device manufacturer, Medtronic, […]
May 13, 2022
The US Food and Drug Administration (FDA) has approved an orally administered version of edaravone (Radicava ORS) for adults with amyotrophic lateral sclerosis (ALS). Edaravone is […]
May 6, 2022
The US Food and Drug Administration (FDA) today warned clinicians of a potential risk for patient exposure to toxic compounds associated with the use of certain […]
May 5, 2022
The US Food and Drug Administration (FDA) has granted standard approval to fam-trastuzumab deruxtecan-nxki (Enhertu) for patients with unresectable or metastatic HER2-positive breast cancer who have […]
May 4, 2022
The US Food and Drug Administration (FDA) has cleared the first in vitro diagnostic to aid in the early detection of Alzheimer’s disease (AD) The Lumipulse […]
May 4, 2022
The US Food and Drug Administration (FDA) has approved two vonoprazan-based treatments for Helicobacter pylori infection: Voquezna Triple Pak (vonoprazan, amoxicillin, clarithromycin) and Voquezna Dual Pak […]